Fact CheckerSign in

NCT06428786Completed

The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function

Source: ClinicalTrials.gov · Last updated 26 Feb 2025

Brief summary (registry, in English)

This study was planned to examine whether different phenotypes of PCOS have an effect on quality of life, depression inventory and sexual function.

Status (registry)
Completed
Study type
Observational
Enrollment
176 (actual)
First submitted
18 May 2024
Start date
25 Sept 2024
Primary completion date
7 Oct 2024
Lead sponsor
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
NCT number
NCT06428786

What you commit to

  • Study type: Observational
  • Participants enrolled: 176
  • From 25 Sept 2024 to the primary completion date, 7 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Endocrine disorders such as hyperprolactinemia, Cushing's syndrome, congenital adrenal hyperplasia, thyroid disorders
  • Neuromuscular, hepatic, pancreatic or gastrointestinal diseases

Age

  • under 18 years of age

Other

  • Users of hormone preparations such as antiandrogens, antidiabetics, glucocorticoids, insulin sensitizers, lipid regulators

Who the study is looking for

  • least 1 year after menarche
  • over 18 years old
  • Patients who have given verbal and written informed consent will be included.

Age in the registry: 18 years to 50 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Etlik Zübeyde Hanım
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.